NOV 07, 2018 08:47 AM PST

Zebrafish Bacterial Gut Protein Delays Death by Septic Shock

WRITTEN BY: Nouran Amin

At the University of Oregon, researchers identified a novel anti-inflammatory protein that is secreted by the common gut bacterium in zebrafish.

The protein, Aeromonas immune modulator (AimA), was found to reduce inflammation in the gut and delay death by septic shock. AimA is a mutual beneficial protein for both the bacterium and their host, the zebrafish.

Image Credit: yourgenome.org

"We used zebrafish as a model host because we could perform many tests and search in an unbiased way for new anti-inflammatory factors,” explains study co-author and professor of biology Karen Guillemin.

Results of the study were published in the journal eLife which sheds light on the role of resident microbes and the levels of an inflammatory response.

"One of the major questions about how we coexist with our microbial inhabitants is why we don't have a massive inflammatory response to the trillions of the bacteria inhabiting our guts," says Guillemin. "We set out to test whether gut bacteria actively secrete factors that prevent an excessive inflammatory response, which would be detrimental not only to the host but also to the bacterial residents.”

Using protein crystallography, researchers were able to identify the structural similarity of AimA to a class of proteins called lipocalins, which include other proteins that modulate inflammation in humans.

"That structural similarity suggested to us that the bacterial protein may function like the human protein" Guillemin said. "In particular, rather than doing something specific to counteract inflammation caused by one kind of bacteria, maybe it was doing something more generally to temper the host's immune response."

Researchers discovered that the AimA protein reduced inflammation but also induced a lethal inflammatory response, known as septic shock. However, what they also found was AimA could counteract the sepsis extending the lifespan of the zebrafish.

"The bacteria were experiencing this inflammation, which is detrimental to them," says Guillemin. "Inflammation involves the production of antimicrobial compounds like reactive oxygen species that are designed for clearing bacteria, so, now, a beneficial bacterium is going to be at a disadvantage if it's experiencing too much of this inflammatory response."

Watch this short video below to learn more about inflammation:

"Most studies of beneficial microbes have focused exclusively on the benefits to the host and have tended to find very generic microbial molecules, such as metabolic byproducts, as the mediators," she said. "The discovery of AimA is exciting because it is a very specific specialized product that a mutualist is making for maintaining that mutualism. I suspect there are many more of these mutualism factors to be found."

 

Findings of the research study are pertinent to drug discovery with applications of treating human diseases associated with excessive inflammation such as intestinal inflammation, including inflammatory bowel diseases, or used in the prevention of chronic inflammation associated with metabolic syndrome and sepsis.

Source: ScienceDaily, eLife

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 23, 2018
Cell & Molecular Biology
SEP 23, 2018
Insulin may be a new Colitis Treatment
Insulin is a necessary medicine for diabetics, but new work shows that insulin may also be used to treat chronic bowel inflammation....
OCT 02, 2018
Drug Discovery
OCT 02, 2018
Mycobacterial Lung Disease, FDA Approves New Drug
New drug seeking to treat antibiotic-resistant lung disease has just been approved by the U.S. Food and Drug Administration. The drug is called ‘Arik...
OCT 31, 2018
Cancer
OCT 31, 2018
Researchers identify a protein marker that induces dormancy in metastatic breast cancer
Researchers at the Mount Sinai hospital identified for the first time a protein marker that could indicate whether breast cancer will further metastasize or remains in a dormant state accordi...
NOV 13, 2018
Cell & Molecular Biology
NOV 13, 2018
The Mechanism of a Cell-penetrating Peptide is Revealed
Cells have a barrier around them, which carefully controls what can move across it. That presents a challenge in pharmaceutical design....
DEC 26, 2018
Drug Discovery
DEC 26, 2018
Novel Water Approach May Improve Drug Design
An understanding of the basic molecular properties of water greatly influences drug design. But, a significant comprehension of water interactions and its ...
JAN 11, 2019
Drug Discovery
JAN 11, 2019
Histamine Improves Long-Term Memory
A recent research study found that histamine could improve people’s long-term memory which may be a prospective treatment option to alleviate symptom...
Loading Comments...